Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06433115 · ClinicalTrials.gov registry record · NA
Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome
A NA study of Diet Intervention, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06433115: Recruiting NA study of Diet Intervention, sponsored by University of Missouri-Columbia.
NCT06433115 is a NA study of Diet Intervention that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06433115, a NA study of Diet Intervention, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.
Primary Outcome
Lipid profile
Conditions Studied
Interventions
- OTHER Lean (≥90%) Grass-Fed Beef
- OTHER Lean (≥90%) Grain-Fed Beef
- OTHER Plant-Based Meat
Study Locations (1)
Missouri
- University of Missouri-Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-06-11 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What NCT06433115 shows while recruiting
NCT06433115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Diet Intervention appearing as the primary indexed condition, and to 3 interventions - of which Lean (≥90%) Grass-Fed Beef is the first listed.
NCT06433115 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06433115 about?
NCT06433115 is a clinical study titled "Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome". This study is investigating the benefits of lean beef consumption on cardiometabolic health and gut microbiome.
What is the current status of trial NCT06433115?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-06-11. Estimated completion is 2027-12-01.
What conditions does trial NCT06433115 study?
This clinical trial studies the following conditions: Diet Intervention.
What interventions are being tested in trial NCT06433115?
The interventions under investigation include: Lean (≥90%) Grass-Fed Beef (OTHER), Lean (≥90%) Grain-Fed Beef (OTHER), Plant-Based Meat (OTHER).
Who is sponsoring clinical trial NCT06433115?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06433115 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06433115's enrollment target sits among peer trials
90 942nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI